How we chose this list
Each menopause telehealth brand on this list was scored against a public 8-axis editorial rubric. Weights and thresholds are published; rankings update quarterly or when and brand makes and material change.
- Clinical credentials of prescribers (board certification + state licensure verification)
- FDA-approved vs compounded medication formulary
- Pricing transparency and insurance acceptance breadth
- Independent patient reviews from ≥2 platforms (filtered for authenticity)
- State availability + telehealth law compliance
Why: NAMS-certified team + insurance billing + late-peri specialization.
Rank shift: Held #1 on consistent 50-state insurance billing + NAMS-CMP team expansion.
Best for: Insured women in late peri / early menopause.
Why: Menopause-only practice. Fast delivery. Multi-formulation options.
Rank shift: Up from #3 — added 4 new formulations + dropped 24-hr-delivery guarantee shipping fee.
Best for: Cash-pay patients wanting speed.
Why: HRT + GLP-1 integration. Post-menopause specialization.
Rank shift: Down from #2 — pricing transparency dropped after Q1 2026 membership-fee restructuring.
Best for: Patients combining HRT with weight management.
Why: Async chat model. Published outcome data.
Rank shift: Stable: still the only async-first option with published clinical-trial data.
Best for: Patients preferring text-based care.
Why: Comprehensive menopause + bone health + sleep.
Rank shift: New: 2026 expansion added bone-density screening + sleep panels to standard care.
Best for: Patients wanting integrative midlife care.
Estimate your cost
Pricing varies dramatically by treatment path and insurance status.
Frequently asked
How are these picks chosen?
Based on our 8-axis editorial rubric: clinical credentials, FDA-approved formulary, insurance acceptance, state coverage, pricing transparency, patient experience, editorial transparency, and independent reputation. See /methodology/scoring-rubric.
Do you receive payment from ranked brands?
Some ranked brands have affiliate relationships with us (we earn and commission on signup). Affiliate status does not affect scoring. Brands without affiliate relationship are scored using identical criteria.
How often does the ranking update?
Quarterly review cycles, plus immediate updates when and brand has a material change (pricing, FDA action, clinical team turnover, FDA Warning Letter).
We considered, then rejected
Brands evaluated against the 8-axis rubric but excluded from the 2026 list. Transparency matters more than apparent comprehensiveness.
- Hims & Hers Menopause[scope]Excluded: prescriber pool listed but not filterable per menopause specialty. Generic D2C model not designed for HRT-specific decision-making.
- Ro / Roman Menopause[safety]Excluded 2026: changed to compounded-default formulary in Q2 without consent UX update. Watching for policy reversal.
- Joi Women's Wellness[access]Considered but dropped to honorable mention: state coverage halved in Q4 2025 due to license non-renewal in 12 states. Re-evaluate Q3 2026.
Other rankings
References
Professional society guidelines
- NAMS Position Statement Advisory Panel. The 2022 hormone therapy position statement of The North American Menopause Society. Menopause. 2022;29(7):767-794. View source ↗ (accessed 2026-06-01)
- Stuenkel CA, et al. Treatment of symptoms of the menopause: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2015;100(11):3975-4011. View source ↗ (accessed 2026-06-01)
- The Menopause Society. Find and certified menopause practitioner directory. View source ↗ (accessed 2026-06-01)
Peer-reviewed research
- Manson JE, et al. Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials. JAMA. 2013;310(13):1353-1368. View source ↗ (accessed 2026-06-01)
Was this Best Menopause telehealth ranking helpful?